#immunology

arGEN-X to Acquire Forte Biosciences in $2.2 Billion Immunology Pipeline Deal

Dutch biotech arGEN-X is buying US-based Forte Biosciences for $2.2 billion, adding a promising anti-CD122 antibody for ...